Physician profile
Nidal Elbaridi
NPI 1780821264
$5,503.15
in general payments reported to CMS, 2019-2025
28 companies · $365 in 2025
The $365 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,539 · 2020: $1,179 · 2021: $638 · 2022: $550 · 2023: $495 · 2024: $737 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,596.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $912.47 | 2019-2021 | |
| Boston Scientific Corporation | $881.48 | 2019-2025 | Wavewriter Alpha Prime 16, Varithena Administration Pack |
| Medtronic, INC. | $659.96 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Nalu Medical, INC. | $604.29 | 2021-2024 | Nalu Neurostimulation System |
| Merz North America, INC. | $567.26 | 2019-2022 | |
| Nevro Corp. | $380.59 | 2019-2023 | Senza |
| Allergan, INC. | $247.38 | 2019-2021 | |
| Siemens Medical Solutions USA, INC. | $194.60 | 2022 | |
| Medtronic USA, INC. | $155.79 | 2019-2020 | |
| Si-Bone, INC. | $151.38 | 2019-2025 | |
| Vertiflex, INC. | $113.06 | 2019 | |
| Avanos Medical | $104.99 | 2019-2023 | Genvisc 850 Sodium Hyaluronate |
| Vertos Medical, INC. | $69.69 | 2019 | |
| Painteq LLC | $64.23 | 2024 | Painteq |
| Pfizer INC. | $53.50 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $45.92 | 2019 | |
| Venclose INC. | $40.43 | 2020 | |
| Galderma Laboratories, L.P. | $39.59 | 2021 | |
| Spinefrontier, INC. | $38.79 | 2021 | |
| Koya Medical, INC. | $26.53 | 2024 | Dayspring, Koya Medical |
| Stratus Medical, LLC | $24.99 | 2023 | Nimbus |
| Pacira Pharmaceuticals Incorporated | $21.64 | 2025 | Zilretta, Exparel, Iovera |
| Spr Therapeutics, INC | $19.69 | 2019 | |
| Collegium Pharmaceutical, INC. | $18.50 | 2020 | |
| Tersera Therapeutics LLC | $17.63 | 2020 | |
| Bioventus LLC | $17.50 | 2020 | |
| Curonix LLC | $17.41 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Merck Sharp & Dohme LLC | $13.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nidal Elbaridi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.